RELIABILITY: Mixed
Congressional researchers wonder whether BBG(X)’s cost and risks were properly analyzed before its rollout.
Continue reading at the original source
Congressional researchers wonder whether BBG(X)’s cost and risks were properly analyzed before its rollout.
Continue reading at the original source